Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs BioAge Labs, Inc. (BIOA)

Aurora Cannabis Inc. and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $341.2M against $254.3M — 1.3× the size. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −1,253.6%) and the higher return on invested capital (−5.58% vs −21.8%). Across the 16 metrics below, Aurora Cannabis Inc. leads on 9 and BioAge Labs, Inc. on 7.

Valuation

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 29.58 2.08
P/B 0.84 0.73 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 0.52 12.22
EV/Sales 1.28 (7.23) 2.87
Earnings yield (27.12%) (46.03%) (15.94%)
Free cash flow yield (11.26%) (101.34%) 0.00%

Profitability

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 100.00% 53.51%
Operating margin (12.13%) (1,401.81%) 0.00%
Net margin (38.12%) (1,253.60%) (2.45%)
Free cash flow margin (17.19%) (2,997.41%) 0.00%
Return on equity (19.85%) (34.56%) (0.80%)
Return on assets (15.19%) (32.05%) (1.67%)
Return on invested capital (5.58%) (21.75%) 0.00%

Growth

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) — 5.22%
EPS growth (last fiscal year) (5,266.67%) 66.21% 42.91%
Revenue growth, 5-year CAGR 3.92% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.04
Current ratio 5.36 15.51 2.41
Net debt to EBITDA 5.11 3.01 1.01

Dividend

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Market cap 341.19m 254.27m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack